No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY UK&IRELAND

Digital health company Numan sold supplements unlawfully for years

Siftedby Sifted
May 20, 2024
Reading Time: 7 mins read
in UK&IRELAND, VENTURE CAPITAL
Share on FacebookShare on Twitter

UK-based digital health startup Numan was selling food supplements for several years without registering as a Food Business Operator (FBO) — something it was required to do by law, Sifted has learned. 

Under UK law, all companies that sell food items — including supplements — are required to register as an FBO 28 days before trading. 

But Numan was selling supplements for at least two years and nine months before it registered as an FBO in February this year, according to WebArchive records of its website. The supplements it sold during this period included vitamin D, and testosterone and fertility support.

Advertisement

Companies that sell food are required to register as FBOs so that their local authority can inspect premises when they need to. Some of these authorities assert that failure to register as a food business is a criminal offence.

When contacted by Sifted, Numan did not deny it had sold supplements before it was registered as an FBO. 

“Our current supplement distribution partner, who procures and delivers our supplements, is registered as a food business operator as at 14 February 2024,” said CEO and founder Sokratis Papafloratos in a statement. He added that the company received “external advice” on “applicable regulations”.

“We continually work with regulatory experts to ensure we are compliant, and continue to stay so,” he said.

The news follows Sifted’s reporting that Numan had recalled supplements that contained restricted ingredients earlier this year. 

Operating 

Numan has been listing supplements for sale on its website since April 2020, according to web archives, when it advertised a “fertility support” supplement that it said was to be taken daily and targeted “key areas” of male fertility.

Numan had broadened that range to include supplements that it said would help improve sleep, boost testosterone and vitamin D and support prostate function by August 2021.

This was before it was registered as an FBO on February 14 2024. 

The Food Standards Agency website, the UK’s food regulatory body, says that “to sell food supplements you must register as a Food Business Operator (FBO) with your local authority.”

Alongside supplements, Numan also prescribes medication for conditions such as erectile dysfunction, hair loss and weight loss — including weight loss jabs like Wegovy. 

Backed by VNV Global and White Star Capital, the company is one of the best-funded of several European startups that have emerged in recent years selling supplements and medication online. 

Advertisement

Since launching in 2018, Numan has raised $72.2m, according to Dealroom, most recently in a £40m ($50m) debt and equity round in February 2022. It says it has served over 500k customers.

“Operational transparency and patient safety are top priorities at Numan,” said Papafloratos in his statement to Sifted. “We make every effort to deliver this at all times, and across all areas of our organisation, as a CQC registered (and regulated) healthcare provider.”

Not the first incident at Numan

In March this year, Sifted learnt that Numan had sent out emails to customers recalling vitamin D supplements that contained Propylparaben and Methylparaben — which are restricted for use in food (including supplements) in the EU and UK.

According to EU law documents, propylparaben has been shown to have effects on sex hormones and the male reproductive organs in juvenile rats. 

“During an independent audit led by Numan to review the ingredients and labelling of all Numan products, we discovered that these ingredients are restricted for use in food products such as supplements,” Papafloratos told Sifted at the time. “The affected product, a Vitamin D spray supplement, that was purchased from a third party supplier, was immediately removed from sale.”

Regulator concerns

These incidents are the latest that have seen online pharmacies and digital health companies come under scrutiny in recent times. 

UK healthtech Manual, which also prescribes medication online, was revealed to be selling weight loss drug Ozempic beyond a UK government deadline to stop doing so, following shortages of the drug. 

There are also growing patient safety concerns linked to the rise of online vendors of supplements and medicines. 

Earlier this year, a BBC investigation found 20 online pharmacies selling restricted drugs without checks like GP approval. 

Duncan Rudkin, CEO of the UK pharmacy regulator the General Pharmaceutical Council, said in a statement that the investigation “raises very serious concerns”.

Read the orginal article: https://sifted.eu/articles/numan-supplements-health-unlawful/

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

DACH

German AI startup akeno raises €4.5 million to automate production planning

May 15, 2025
SCANDINAVIA&BALTICS

Meet Wave Ventures, the Finnish Gen Z VC fund for Gen Z Founders announcing a €7 million fund

May 15, 2025
REAL ESTATE

New UK public sector valuer rotation report issued by RICS

May 15, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

Benchmark backs one-year-old AI legaltech Leya in $10.5m seed round

Can Sana’s AI really reason? Yes, says founder Joel Hellermark

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart